# FDA OTHER_CORRESPONDENCE - Unknown Company - July 16, 2016

Source: https://www.globalkeysolutions.net/records/other_correspondence/unknown-company/3affdc4e-7fd6-4ca9-874a-f7c45bf83a5e

> FDA OTHER_CORRESPONDENCE for Unknown Company on July 16, 2016. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: OTHER_CORRESPONDENCE
- Inspection Date: 2016-07-16
- Product Type: Drugs
- Office Name: Office of Pharmaceutical Quality Operations

## Related Documents

- [483_RESPONSE - 2016-01-29](https://www.globalkeysolutions.net/records/483_response/unknown-company/9c3d9cb6-5c40-4b6e-8583-a79cdb64f346)
- [OTHER_CORRESPONDENCE - 2015-07-24](https://www.globalkeysolutions.net/records/other_correspondence/unknown-company/0eceeb47-3712-4b94-999b-8ac2f77435c9)
- [RESUME - Unknown Date](https://www.globalkeysolutions.net/records/resume/unknown-company/3362a8d9-3527-4b16-b028-a7a9b5d63941)
- [RESUME - Unknown Date](https://www.globalkeysolutions.net/records/resume/unknown-company/2e526b9d-c43a-4d0b-84be-03a886b460ba)
- [483_RESPONSE - 2014-06-27](https://www.globalkeysolutions.net/records/483_response/unknown-company/40dcf4d8-d200-4750-8415-263f517dfaed)

## Related Officers

- [Compliance Officer](https://www.globalkeysolutions.net/people/thao-ta/6cf2f58b-cb1b-463f-8861-b81ba0780db6)
- [John W. Diehl, M.S.Program Division](https://www.globalkeysolutions.net/people/john-w-diehl/83ce50c4-b3cb-42ca-96eb-0c988068e08f)
- [Rebecca M. Shanahan](https://www.globalkeysolutions.net/people/rebecca-m-shanahan/97826241-6ecf-4c6a-941f-a58290645d76)
- [Bourjois S. Abboud](https://www.globalkeysolutions.net/people/bourjois-s-abboud/aa8c4485-05f0-436f-ab83-4729baf7d640)
- [Megan M. Snyder](https://www.globalkeysolutions.net/people/megan-m-snyder/be6cdf0b-51d2-4e48-b3a7-9bc94defabe6)

Office: https://www.globalkeysolutions.net/offices/office-of-pharmaceutical-quality-operations/6b0153a9-c1d1-46a5-8b10-836d2ae44ffe